Deccan Health Care Ltd

542248

Overview

    • Equity Style Box

      Small Blend

    • Sector

      Healthcare

    • Industry

      Drug Manufacturers - Specialty & Generic

    • Day Range

      18.71 – 19.78

    • Year Range

      16.00 – 39.10

    • Market Cap

      445.3190 Mil

    • Volume / Avg

      148.7 k / 48.4 k

    • Price / Sales

      0.68

    • Price / Book

      0.41

    • Price / Earnings

      44.07

    • Forward Div Yield

      0.00%

    • Trailing Div Yield

      —

Login To Show Full Chart

Summary

Fair Value Assessment
Undervalued (33% Discount)
Fair ValueQ28.98UncertaintyVery High
Close Price19.39Mar 25, 2025
Market Closed
₹ 19.01
Price Down by 0.38 | 1.96 %
Trading Information Business Description
Previous Close
19.39
Day Range
18.71 – 19.78
Year Range
16.00 – 39.10
Bid / Ask
—
Market Cap
445.3 Mil
Volume / Average
148.7 k / 48.4 k
Beta (5-Year)
1.73
Shares Outstanding
23.43 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Deccan Health Care Ltd is into developing, manufacturing, and marketing a broad range of healthcare products including nutraceutical, cosmeceutical, and ayurveda products ( Fast Moving Consumer Health Products). Its products are Nutraceutical Food Products and other supplements and medicines. The Company is operating into a single segment of manufacturing of nutraceutical products. The company operates in India as well as exports its products to other countries and the maximum of its revenue comes from India.
Contact
House No. 6-3-348/4, Dwarakapuri Colony Punjagutta, Hyderabad, TG 500082
T +91 4047096427
www.deccanhealthcare.co.in opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Dec 31, 2024
Fiscal Year End
Mar 31, 2025
Employees
57
As of Mar 31, 2024

Key Metrics

Income Statement (in Mil, except ratios)
12/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
702.79 597.29 450.22 331.76 337.76 422.44
Revenue Growth %
17.88% 32.67% 35.72% -1.78% -20.05% -4.53%
Gross Profit
236.44 190.33 183.49 173.11 144.55 250.24
Gross Profit Margin %
33.64% 31.87% 40.76% 52.18% 42.80% 59.24%
Operating Income
17.76 22.85 6.09 41.62 15.27 102.58
Operating Margin %
2.53% 3.83% 1.35% 12.54% 4.52% 24.28%
EBIT
17.41 22.56 5.90 6.51 5.88 102.57
EBIT Margin %
2.48% 3.78% 1.31% 1.96% 1.74% 24.28%
EBITDA
31.91 37.22 20.17 21.24 20.54 116.75
EBITDA Margin %
4.54% 6.23% 4.48% 6.40% 6.08% 27.64%
Net Income
11.63 14.93 3.64 3.23 3.90 100.87
Net Profit Margin %
1.66% 2.50% 0.81% 0.97% 1.15% 23.88%
Basic EPS
0.53 0.80 0.22 0.21 0.25 6.42
Diluted EPS
0.44 0.80 0.22 0.21 0.25 6.42
Normalized EPS
— — — — — —
Total Dividends per Share
— — — — — —
Balance Sheet (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Total Assets
1,131.83 1,080.48 968.53 906.26 922.68 929.90
Total Liabilities
140.19 111.32 152.90 136.80 156.46 167.58
Total Debt
12.69 18.95 14.10 12.51 10.32 12.94
Total Equity
991.64 969.16 815.63 769.46 766.22 762.32
Cash And Cash Equivalents
19.55 26.03 14.34 26.68 32.23 34.45
Working Capital
825.64 806.87 638.77 574.70 537.46 522.61
Shares Outstanding (Mil)
— — 17.04 15.71 — —
Book Value Per Share
— 46.90 47.86 48.97 48.76 48.51
Total Debt To Equity
0.01 0.02 0.02 0.02 0.01 0.02
Cash Flow Statement (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
-138.22 -125.51 -66.06 -5.73 2.19 10.35
Cash From Investing Activities
-3.99 -3.00 2.51 -0.49 -0.72 -17.71
Cash From Financing Activities
141.98 140.44 51.21 0.67 -3.70 -2.96
Capital Expenditures
— 3.11 — 1.12 1.58 18.11
Free Cash Flow
— 25.03 9.72 16.48 16.80 97.25
Change in Cash
-0.22 11.93 -12.34 -5.55 -2.23 -10.33

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership

There is no Ownership data available.

STOCKS
MUTUAL FUNDS
ADITYABIRLAAXISBajajBANDHANBARODABNPBOICANARADSPEDELWEISSFRANKLINTEMPLETONGROWWHDFCHELIOSHSBCICICIIIFLINVESCOITIJMKOTAKLICMahindraManulifeMIRAEMOTILALNAVINipponNJOldBridgePGIMPPFASQUANTQUANTUMSAMCOSBISHRIRAMSUNDARAMTATATAURUSTrustUNIONUTIWhiteOakZERODHA
INSURANCE FUNDS
ABSLAEGONAGEASFEDERALAVIVABAJAJALLIANZBHARTIAXACANARAHSBCORIENTBANKEDELWEISSTOKIOEXIDEFUTUREGENERALIHDFCICICIPRUDENTIALINDIAFIRSTKOTAKMAHINDRALICMAXLIFEPNBMETLIFEPRAMERICARELIANCENIPPONSAHARASBISHRIRAMSTARUNIONDAI-ICHITATAAIA

About Us

Connect With Us

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top